当前位置: 首页 > 详情页

Postoperative neutrophil-lymphocyte ratio predicts unfavorable outcome of acute ischemic stroke patients who achieve complete reperfusion after thrombectomy

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China. [2]China International Neuroscience Institute (China-INI), Beijing, China. [3]Department of Neurosurgery, Liaocheng Brain Hospital, Liaocheng, China. [4]Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China. [5]Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China. [6]Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China. [7]Department of Neurology, Loma Linda University Health, Loma Linda, CA, United States. [8]Department of Interventional Neuroradiology, Xuanwu Hospital, Capital Medical University, Beijing, China. [9]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. [10]Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
出处:
ISSN:

关键词: acute ischemic stroke endovascular treatment NLR inflammation prognosis reperfusion

摘要:
Only approximately half of anterior circulation large vessel occlusion (LVO) patients receiving endovascular treatment (EVT) have a favorable outcome. The aim of this study was to explore the association of dynamic inflammatory markers (i.e., neutrophil to lymphocyte ratios, NLR, measured at different times after EVT) as well as other potential influencing factors with unfavorable outcome among acute ischemic stroke (AIS) patients who achieved complete reperfusion after EVT.Patients treated with EVT for LVO between January 2019 to December 2021 were prospectively enrolled. Complete reperfusion was defined as modified thrombolysis in cerebral infarction (mTICI) grade 3. A modified Rankin scale at 90 days (mRS90) of 3-6 was defined as unfavorable outcome (i.e., futile reperfusion). A logistic regression analysis was performed with unfavorable outcome as a dependent variable. The receiver operating characteristic (ROC) curve and the area under the curve (AUC) were then used to determine the diagnostic values of NLR and other relevant factors.170 patients with complete reperfusion (mTICI 3) were included in this study. Unfavorable outcome was observed in 70 (41.2%). Higher NLR within 24h (p=0.017) and at 3-7d (p=0.008) after EVT were an independent risk factors for unfavorable outcome at 3 months. In addition, older age, higher NIHSS scores, poor collaterals, and general anesthesia were independent predictors of unfavorable outcomes. When accounting for NLR, the diagnostic efficiency improved compared to conventional characteristics.Our findings suggest that advanced age, increased stroke severity, poor collaterals, general anesthesia, and NLR are independent predictors for an unfavorable clinical outcome following complete reperfusion after EVT. Neuroinflammation may merit particular attention in future studies.Copyright © 2022 Feng, Bai, Li, Cao, Xu, Yu, Fu, Tian, Guo, Wang, Sha, Chen, Gao, Wang, Chen, Ma, Chen, Dmytriw, Regenhardt, Lu, Ma, Yang and Jiao.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
JCR分区:
出版当年[2020]版:
Q1 IMMUNOLOGY
最新[2023]版:
Q1 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China. [2]China International Neuroscience Institute (China-INI), Beijing, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China. [2]China International Neuroscience Institute (China-INI), Beijing, China. [8]Department of Interventional Neuroradiology, Xuanwu Hospital, Capital Medical University, Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院